- Home
- CNTA vs QTWO Comparison
CNTA vs QTWO Comparison
Compare CNTA & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | QTWO |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.9B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CNTA | QTWO |
|---|---|---|
| Price | $39.51 | $49.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $42.00 | ★ $82.64 |
| AVG Volume (30 Days) | ★ 3.9M | 574.6K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.13 | ★ 225.00 |
| EPS | N/A | ★ 0.80 |
| Revenue | $15,000,000.00 | ★ $193,978,000.00 |
| Revenue This Year | N/A | $12.48 |
| Revenue Next Year | N/A | $10.18 |
| P/E Ratio | ★ N/A | $60.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $44.65 |
| 52 Week High | $40.26 | $95.10 |
Technical Indicators
Market Signals| Indicator | CNTA | QTWO |
|---|---|---|
| Relative Strength Index (RSI) | 76.56 | 50.31 |
| Support Level | $24.80 | $45.41 |
| Resistance Level | N/A | $52.96 |
| Average True Range (ATR) | 1.33 | 1.86 |
| MACD | 1.25 | 0.53 |
| Stochastic Oscillator | 94.93 | 75.87 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About QTWO Q2 Holdings Inc.
Q2 Holdings Inc provides digital solutions to financial institutions, financial technology companies, and alternative finance companies, seeking to incorporate banking into their customer engagement and servicing strategies. The company helps its clients with supervisory, consumer protection, privacy, third-party risk management requirements, and cyber threats and fraud, among other applications, by offering a portfolio of digital solutions, which comprises its digital banking offerings, digital lending and relationship pricing solutions, risk and fraud solutions, as well as Q2 Innovation Studio and Helix. Q2 derives the majority of its revenue from subscription fees for the use of its hosted solutions.